Miljkovic Milos
Chief Medical Officer
Miljkovic Milos has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jan 8, 2026.
On the most recent filing, Miljkovic Milos is listed as Chief Medical Officer at Cartesian Therapeutics, Inc. Inside the rolling window, Miljkovic Milos reported no open-market purchases and 1 open-market sale totaling $24K in RNAC.
Companies traded
Other insiders at RNAC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$24K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Miljkovic Milos made?
Miljkovic Milos has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Miljkovic Milos trade?
Miljkovic Milos has filed SEC Form 4 disclosures for 1 company, including RNAC.
When was Miljkovic Milos's most recent SEC Form 4 filing?
Miljkovic Milos's most recent SEC Form 4 filing on Tracefour is dated Jan 8, 2026.
What is Miljkovic Milos's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Miljkovic Milos is listed as Chief Medical Officer.
What is Miljkovic Milos's total buy and sell value in the current window?
Inside the rolling retention window, Miljkovic Milos bought $0 and sold $24K based on SEC Form 4 filings.
What was Miljkovic Milos's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,573 RNAC shares on 2026-01-06, worth $24K, per SEC Form 4 filings.